← Back to Search

Device

TearCare for Meibomian Gland Dysfunction (OLYMPIA Trial)

N/A
Recruiting
Research Sponsored by Sight Sciences, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 1 month
Awards & highlights

OLYMPIA Trial Summary

TearCare System to Treat Dry Eye Disease

Eligible Conditions
  • Meibomian Gland Dysfunction
  • Dry Eye Syndrome

OLYMPIA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~1 month
This trial's timeline: 3 weeks for screening, Varies for treatment, and 1 month for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Meibomian Gland Secretion Score
Tear Break-Up Time
Secondary outcome measures
Conjunctival staining score
Corneal staining score
Eye Dryness Score
+4 more

OLYMPIA Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: TearCareExperimental Treatment1 Intervention
Subjects will have heat applied to the eyelids for 15 minutes followed by manual expression of the meibomian glands.
Group II: LipiFlowActive Control1 Intervention
Subjects will have heat and pressure applied to the eyelids for 12 minutes.

Find a Location

Who is running the clinical trial?

Sight Sciences, Inc.Lead Sponsor
12 Previous Clinical Trials
877 Total Patients Enrolled
1 Trials studying Meibomian Gland Dysfunction
350 Patients Enrolled for Meibomian Gland Dysfunction

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
~23 spots leftby Apr 2025